Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02963818 · ClinicalTrials.gov registry record · Phase 1
Smartphone Technology: Young Adult Drinking
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 110
- Enrollment target
NCT02963818: Completed Phase 1 study, sponsored by University of Florida.
NCT02963818 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 110 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02963818, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 110 participants
- Enrollment target
Study Summary
Exploring technology based tools to reduce drinking is important. The purpose of this research study is to compare different BAC monitoring apps for their effects on alcohol drinking and ratings of usability among young adults.This study will be conducted in six phases: a web-based and in-person screening assessment; brief counseling session on the day before the alcohol drinking session; brief appointment on the day of the alcohol drinking session; alcohol drinking session; two-week field period; and a follow-up appointment. Participation in this study will last approximately two months.
Primary Outcome
Compare forms of mobile technology for their effects on alcohol consumption
Interventions
- OTHER Smartphone breathalyzer device/app use
- OTHER BAC estimator app use
- OTHER Text messaging procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2016-11 |
| Est. Completion | 2020-06-20 |
| Phase | Phase 1 |
What the finished NCT02963818 record still lists
NCT02963818 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% higher).
The record links to 0 conditions, and to 3 interventions - of which Smartphone breathalyzer device/app use is the first listed.
NCT02963818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02963818 about?
NCT02963818 is a clinical study titled "Smartphone Technology: Young Adult Drinking". Exploring technology based tools to reduce drinking is important. The purpose of this research study is to compare different BAC monitoring apps for their effects on alcohol drinking and ratings of usability among young adults.This study will be conducted in six phases: a web-based and in-person scr...
What is the current status of trial NCT02963818?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 110 participants. The study started on 2016-11. Estimated completion is 2020-06-20.
What interventions are being tested in trial NCT02963818?
The interventions under investigation include: Smartphone breathalyzer device/app use (OTHER), BAC estimator app use (OTHER), Text messaging procedure (OTHER).
Who is sponsoring clinical trial NCT02963818?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02963818's enrollment target sits among peer trials
110 514th of 2000 higher than 1,479 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia